Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derek G Power

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
Clinical Nutrition ESPEN|January 25, 2021
A national survey of oncology survivors examining nutrition attitudes, problems and behaviours, and access to dietetic care throughout the cancer journeyErin S Sullivan, Niamh Rice, Elaine Kingston, et al.
The Oncologist|November 30, 2020
Assessing the Quality of Care Delivered to Transgender and Gender Diverse Patients with Cancer in Ireland: A Case SeriesCarolyn Moloney, Margaret Allen, Derek G Power, et al.
Annals of Surgery|June 4, 2008
Barrett esophagus: prevalence of central adiposity, metabolic syndrome, and a proinflammatory stateAoife M Ryan, Laura A Healy, Derek G Power, et al.
Journal of the Academy of Nutrition and Dietetics|April 27, 2026
Incorporating CT-Derived Body Composition analysis into the Global Leadership Initiative on Malnutrition criteria is associated with overall survival: findings from an international cancer cohortClodagh Scannell, Erin Stella Sullivan, Ross D Dolan, et al.
American Journal of Clinical Oncology|April 2, 2014
Body Composition by Computed Tomography as a Predictor of Toxicity in Patients With Renal Cell Carcinoma Treated With SunitinibSamantha J Cushen, Derek G Power, Min Y Teo, et al.
Urologic Oncology|March 28, 2008
Cisplatin and gemcitabine in the management of metastatic penile cancerDerek G Power, David J Galvin, Sinead Cuffe, et al.
Biochimica Et Biophysica Acta|July 5, 2016
Glycolysis inhibition as a cancer treatment and its role in an anti-tumour immune responseKheshwant S Gill, Philana Fernandes, Tracey R O'Donovan, et al.
Lung Cancer Management|June 7, 2023
Real-world outcomes and toxicity of adjuvant chemotherapy in NSCLC: a single-center experienceChristopher Cronin, Shahid Iqbal, Abdul R Farooq, et al.
Cancers|July 14, 2023
Are CT-Derived Muscle Measurements Prognostic, Independent of Systemic Inflammation, in Good Performance Status Patients with Advanced Cancer?Josh McGovern, Ross D Dolan, Claribel Simmons, et al.
Anticancer Research|January 30, 2022
Therapeutic Response Evaluation in Advanced Melanoma Patients Incorporating Plasma cfDNA, LDH, VEGF, PD-L1, and IFN-γ MeasurementsMichael I Ita, Jiang H Wang, Cynthia C Heffron, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
Clinical Nutrition ESPEN|January 25, 2021
A national survey of oncology survivors examining nutrition attitudes, problems and behaviours, and access to dietetic care throughout the cancer journeyErin S Sullivan, Niamh Rice, Elaine Kingston, et al.
The Oncologist|November 30, 2020
Assessing the Quality of Care Delivered to Transgender and Gender Diverse Patients with Cancer in Ireland: A Case SeriesCarolyn Moloney, Margaret Allen, Derek G Power, et al.
Annals of Surgery|June 4, 2008
Barrett esophagus: prevalence of central adiposity, metabolic syndrome, and a proinflammatory stateAoife M Ryan, Laura A Healy, Derek G Power, et al.
Journal of the Academy of Nutrition and Dietetics|April 27, 2026
Incorporating CT-Derived Body Composition analysis into the Global Leadership Initiative on Malnutrition criteria is associated with overall survival: findings from an international cancer cohortClodagh Scannell, Erin Stella Sullivan, Ross D Dolan, et al.
American Journal of Clinical Oncology|April 2, 2014
Body Composition by Computed Tomography as a Predictor of Toxicity in Patients With Renal Cell Carcinoma Treated With SunitinibSamantha J Cushen, Derek G Power, Min Y Teo, et al.
Urologic Oncology|March 28, 2008
Cisplatin and gemcitabine in the management of metastatic penile cancerDerek G Power, David J Galvin, Sinead Cuffe, et al.
Biochimica Et Biophysica Acta|July 5, 2016
Glycolysis inhibition as a cancer treatment and its role in an anti-tumour immune responseKheshwant S Gill, Philana Fernandes, Tracey R O'Donovan, et al.
Lung Cancer Management|June 7, 2023
Real-world outcomes and toxicity of adjuvant chemotherapy in NSCLC: a single-center experienceChristopher Cronin, Shahid Iqbal, Abdul R Farooq, et al.
Cancers|July 14, 2023
Are CT-Derived Muscle Measurements Prognostic, Independent of Systemic Inflammation, in Good Performance Status Patients with Advanced Cancer?Josh McGovern, Ross D Dolan, Claribel Simmons, et al.
Anticancer Research|January 30, 2022
Therapeutic Response Evaluation in Advanced Melanoma Patients Incorporating Plasma cfDNA, LDH, VEGF, PD-L1, and IFN-γ MeasurementsMichael I Ita, Jiang H Wang, Cynthia C Heffron, et al.
Pageof 10